Adverse Neuropsychiatric Events Associated with Varenicline: A Case Series
Varenicline is an orally administered α4β2 nicotinic acetylcholine (Ach) receptor, partial agonist. This drug has been known to be more effective in the treatment of nicotine withdrawal than bupropion and nicotine replacement therapies. Besides this effectiveness, it has some systemic and...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Psychopharmacology Association
2021-03-01
|
| Серія: | Psychiatry and Behavioral Sciences |
| Предмети: | |
| Онлайн доступ: | http://www.ejmanager.com/fulltextpdf.php?mno=302645354 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|